|
US6592877B1
(en)
*
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
US7541020B2
(en)
*
|
1997-05-08 |
2009-06-02 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US6764840B2
(en)
|
1997-05-08 |
2004-07-20 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
AU773921B2
(en)
*
|
1997-05-08 |
2004-06-10 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US6303347B1
(en)
*
|
1997-05-08 |
2001-10-16 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US7063967B2
(en)
|
1997-05-08 |
2006-06-20 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
|
US7083796B2
(en)
*
|
2000-06-20 |
2006-08-01 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
|
NZ515322A
(en)
*
|
1999-05-13 |
2004-03-26 |
Wyeth Corp |
Adjuvant combination formulations
|
|
EP1229931A4
(en)
|
1999-10-07 |
2003-05-28 |
Corixa Corp |
FUSION PROTEINS FROM MYCOBACTERIUM TUBERCULOSIS
|
|
IL151097A0
(en)
|
2000-02-23 |
2003-04-10 |
Smithkline Beecham Biolog |
Tumour-specific animal proteins
|
|
AU2001241738A1
(en)
*
|
2000-02-25 |
2001-09-03 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
|
US6699846B2
(en)
*
|
2000-03-17 |
2004-03-02 |
Corixa Corporation |
Mono- and disaccharides for the treatment of nitric oxide related disorders
|
|
ES2309064T3
(es)
*
|
2000-04-13 |
2008-12-16 |
Corixa Corporation |
Composiciones inmunoestimulantes que comprenden un fosfato de aminoalquil glucosaminida y qs-21.
|
|
US20030139356A1
(en)
*
|
2001-05-18 |
2003-07-24 |
Persing David H. |
Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
|
|
US20030105032A1
(en)
*
|
2000-05-19 |
2003-06-05 |
Persing David H. |
Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
|
|
HU230847B1
(en)
|
2000-05-19 |
2018-08-28 |
Corixa Corp |
Prophylactic and therapeutic treatment of infectious and other diseases with mono and disaccharide-based compounds
|
|
CA2417806C
(en)
*
|
2000-08-04 |
2011-05-10 |
Corixa Corporation |
New immunoeffector compounds
|
|
IL155690A0
(en)
*
|
2000-11-10 |
2003-11-23 |
Wyeth Corp |
Adjuvant combination formulations
|
|
EP1850850A4
(en)
*
|
2000-12-08 |
2011-06-15 |
3M Innovative Properties Co |
COMPOSITIONS AND METHOD FOR TARGETED ADMINISTRATION OF IMMUNE RESPONSE MODIFICATORS
|
|
WO2002053761A2
(en)
|
2000-12-28 |
2002-07-11 |
Wyeth |
Recombinant protective protein from $i(streptococcus pneumoniae)
|
|
BR0208874A
(pt)
*
|
2001-04-13 |
2004-06-22 |
Wyeth Corp |
Proteìnas superficiais de streptococcus pyogenes
|
|
US20070128229A1
(en)
*
|
2002-04-12 |
2007-06-07 |
Wyeth |
Surface proteins of Streptococcus pyogenes
|
|
EP2277897A1
(en)
|
2001-04-16 |
2011-01-26 |
Wyeth Holdings Corporation |
Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
|
|
JP2005504513A
(ja)
|
2001-05-09 |
2005-02-17 |
コリクサ コーポレイション |
前立腺癌の治療及び診断のための組成物及び方法
|
|
US7361352B2
(en)
|
2001-08-15 |
2008-04-22 |
Acambis, Inc. |
Influenza immunogen and vaccine
|
|
MX339524B
(es)
*
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
DE60234386D1
(de)
*
|
2002-02-04 |
2009-12-24 |
Corixa Corp |
Neue immuneffektor-verbindungen
|
|
RU2288723C2
(ru)
*
|
2002-02-04 |
2006-12-10 |
Корикса Корпорейшн |
Профилактическое и терапевтическое лечение инфекционных и других заболеваний с помощью иммуноэффективных соединений
|
|
AU2002255513B2
(en)
|
2002-02-04 |
2008-03-06 |
Corixa Corporation |
Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
|
|
US7030094B2
(en)
*
|
2002-02-04 |
2006-04-18 |
Corixa Corporation |
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21
|
|
US6911434B2
(en)
*
|
2002-02-04 |
2005-06-28 |
Corixa Corporation |
Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
|
|
RU2289585C2
(ru)
*
|
2002-02-04 |
2006-12-20 |
Корикса Корпорейшн |
Новые аминоалкилглюкозаминидфосфатные соединения, иммуностимулирующая фармацевтическая композиция, их содержащая, и способ индуцирования иммунного ответа
|
|
US20030190333A1
(en)
*
|
2002-02-04 |
2003-10-09 |
Corixa Corporation |
Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
|
|
US7026465B2
(en)
*
|
2002-02-15 |
2006-04-11 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis
|
|
US7351413B2
(en)
*
|
2002-02-21 |
2008-04-01 |
Lorantis, Limited |
Stabilized HBc chimer particles as immunogens for chronic hepatitis
|
|
HUE025145T2
(en)
*
|
2002-02-22 |
2016-01-28 |
Meda Ab |
A method for reducing and treating immunosuppression induced by ultraviolet B radiation
|
|
AU2003213640A1
(en)
*
|
2002-02-28 |
2003-09-16 |
Corixa Corporation |
Methods of modulating dendritic cells using adjuvants
|
|
AU2003218162B2
(en)
|
2002-03-15 |
2009-10-29 |
The Curators Of The University Of Missouri |
Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
|
|
JP5014573B2
(ja)
|
2002-05-09 |
2012-08-29 |
オンコサイレオン インコーポレーテッド |
脂質ａおよび他の炭水化物リガンド類似体
|
|
US7288640B2
(en)
*
|
2002-07-08 |
2007-10-30 |
Corixa Corporation |
Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
|
|
ES2456066T3
(es)
*
|
2002-07-08 |
2014-04-21 |
Corixa Corporation |
Procesos para la producción de fosfato de aminoalquil glucosaminida e inmunoefectores disacáridos, e intermedios para ello
|
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
US7301554B2
(en)
*
|
2002-09-20 |
2007-11-27 |
Ricoh Company, Ltd. |
Light scanning device, scanning line adjusting method, scanning line adjusting control method, image forming apparatus, and image forming method
|
|
EP2572714A1
(en)
*
|
2002-12-30 |
2013-03-27 |
3M Innovative Properties Company |
Immunostimulatory Combinations
|
|
US7960522B2
(en)
*
|
2003-01-06 |
2011-06-14 |
Corixa Corporation |
Certain aminoalkyl glucosaminide phosphate compounds and their use
|
|
CN101863930A
(zh)
*
|
2003-01-06 |
2010-10-20 |
科里克萨有限公司 |
一些氨烷基氨基葡糖苷磷酸酯化合物和它们的用途
|
|
JP2006517974A
(ja)
*
|
2003-02-13 |
2006-08-03 |
スリーエム イノベイティブ プロパティズ カンパニー |
Ｉｒｍ化合物およびトル様受容体８に関する方法および組成物
|
|
EP1599726A4
(en)
*
|
2003-02-27 |
2009-07-22 |
3M Innovative Properties Co |
SELECTIVE MODULATION OF TLR-MEDIATED BIOLOGICAL ACTIVITY
|
|
JP2006519866A
(ja)
|
2003-03-04 |
2006-08-31 |
スリーエム イノベイティブ プロパティズ カンパニー |
Ｕｖ誘発性の表皮の新形成の予防的治療
|
|
AU2004220465A1
(en)
|
2003-03-13 |
2004-09-23 |
3M Innovative Properties Company |
Method of tattoo removal
|
|
KR20050109562A
(ko)
*
|
2003-03-13 |
2005-11-21 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
피부의 질을 개선시키는 방법
|
|
US20040192585A1
(en)
*
|
2003-03-25 |
2004-09-30 |
3M Innovative Properties Company |
Treatment for basal cell carcinoma
|
|
US20040265351A1
(en)
*
|
2003-04-10 |
2004-12-30 |
Miller Richard L. |
Methods and compositions for enhancing immune response
|
|
EP1615665A4
(en)
*
|
2003-04-10 |
2010-10-06 |
3M Innovative Properties Co |
DISTRIBUTION OF THE IMMUNE RESPONSE MODIFYING LINKS
|
|
CN1852711A
(zh)
*
|
2003-08-05 |
2006-10-25 |
3M创新有限公司 |
使用免疫响应调节化合物的传染病预防
|
|
BRPI0413558A
(pt)
|
2003-08-12 |
2006-10-17 |
3M Innovative Properties Co |
compostos contendo imidazo substituìdo por hidroxilamina
|
|
JP2007504145A
(ja)
*
|
2003-08-25 |
2007-03-01 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫刺激性の組み合わせおよび治療
|
|
AU2004268625B2
(en)
|
2003-08-27 |
2011-03-31 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted imidazoquinolines
|
|
AU2004270201A1
(en)
*
|
2003-09-05 |
2005-03-17 |
3M Innovative Properties Company |
Treatment for CD5+ B cell lymphoma
|
|
US7544697B2
(en)
|
2003-10-03 |
2009-06-09 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and analogs thereof
|
|
AR046046A1
(es)
|
2003-10-03 |
2005-11-23 |
3M Innovative Properties Co |
Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas.
|
|
JP2007509987A
(ja)
*
|
2003-10-31 |
2007-04-19 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫応答調節剤化合物による好中球活性化
|
|
EP1685129A4
(en)
|
2003-11-14 |
2008-10-22 |
3M Innovative Properties Co |
OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
|
|
CA2545825A1
(en)
|
2003-11-14 |
2005-06-02 |
3M Innovative Properties Company |
Hydroxylamine substituted imidazo ring compounds
|
|
CA2547020C
(en)
|
2003-11-25 |
2014-03-25 |
3M Innovative Properties Company |
1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
|
|
US20050226878A1
(en)
*
|
2003-12-02 |
2005-10-13 |
3M Innovative Properties Company |
Therapeutic combinations and methods including IRM compounds
|
|
US8940755B2
(en)
*
|
2003-12-02 |
2015-01-27 |
3M Innovative Properties Company |
Therapeutic combinations and methods including IRM compounds
|
|
JP4696079B2
(ja)
|
2003-12-17 |
2011-06-08 |
ヤンセン アルツハイマー イミュノセラピー |
Ａβ免疫原性ペプチド担体結合物およびそれの製造方法
|
|
KR101157694B1
(ko)
|
2003-12-17 |
2012-06-20 |
와이어쓰 엘엘씨 |
면역원성 펩티드 캐리어 컨쥬게이트 및 이의 제조 방법
|
|
JP2007517035A
(ja)
|
2003-12-29 |
2007-06-28 |
スリーエム イノベイティブ プロパティズ カンパニー |
アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
|
|
US20050239735A1
(en)
*
|
2003-12-30 |
2005-10-27 |
3M Innovative Properties Company |
Enhancement of immune responses
|
|
EP1699788A2
(en)
|
2003-12-30 |
2006-09-13 |
3M Innovative Properties Company |
Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
|
|
WO2005094531A2
(en)
|
2004-03-24 |
2005-10-13 |
3M Innovative Properties Company |
Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
|
MXPA06012451A
(es)
*
|
2004-04-28 |
2007-01-31 |
3M Innovative Properties Co |
Composiciones y metodos para vacunacion por la mucosa.
|
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
|
JP2008502363A
(ja)
|
2004-05-21 |
2008-01-31 |
ワイス |
Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓの改変型フィブロネクチン結合タンパク質
|
|
US20050267145A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Merrill Bryon A |
Treatment for lung cancer
|
|
US8017779B2
(en)
|
2004-06-15 |
2011-09-13 |
3M Innovative Properties Company |
Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
|
|
TW200613554A
(en)
|
2004-06-17 |
2006-05-01 |
Wyeth Corp |
Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
|
|
US8026366B2
(en)
|
2004-06-18 |
2011-09-27 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
|
WO2006065280A2
(en)
|
2004-06-18 |
2006-06-22 |
3M Innovative Properties Company |
Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
|
|
WO2006038923A2
(en)
|
2004-06-18 |
2006-04-13 |
3M Innovative Properties Company |
Aryl substituted imidazonaphthyridines
|
|
WO2006026470A2
(en)
*
|
2004-08-27 |
2006-03-09 |
3M Innovative Properties Company |
Hiv immunostimulatory compositions
|
|
EP1804583A4
(en)
*
|
2004-10-08 |
2009-05-20 |
3M Innovative Properties Co |
ADJUVANT FOR DNA VACCINE
|
|
EP2298341A3
(en)
|
2004-10-21 |
2011-07-13 |
Wyeth LLC |
Immunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens
|
|
PL1830876T3
(pl)
|
2004-12-30 |
2015-09-30 |
Meda Ab |
Zastosowanie imikwimodu do leczenia przerzutów do skóry wywodzących się od guza stanowiącego raka piersi
|
|
JP5543068B2
(ja)
|
2004-12-30 |
2014-07-09 |
スリーエム イノベイティブ プロパティズ カンパニー |
キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
|
|
EP1831221B1
(en)
|
2004-12-30 |
2012-08-08 |
3M Innovative Properties Company |
Substituted chiral fused 1,2 imidazo 4,5-c ring compounds
|
|
AU2006210392A1
(en)
|
2005-02-04 |
2006-08-10 |
Coley Pharmaceutical Group, Inc. |
Aqueous gel formulations containing immune response modifiers
|
|
AU2006213746A1
(en)
|
2005-02-11 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
|
|
AU2006232375A1
(en)
|
2005-04-01 |
2006-10-12 |
Coley Pharmaceutical Group, Inc. |
1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
|
|
EP1869043A2
(en)
|
2005-04-01 |
2007-12-26 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridine-1,4-diamines and analogs thereof
|
|
US7709001B2
(en)
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
EP3311836A1
(en)
|
2005-04-08 |
2018-04-25 |
Wyeth LLC |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
CA2605808A1
(en)
*
|
2005-04-25 |
2006-11-02 |
3M Innovative Properties Company |
Immunostimulatory compositions
|
|
US20080213318A1
(en)
*
|
2005-07-05 |
2008-09-04 |
Hawaii Biotech, Inc. |
Malaria MSP-1 C-terminal enhanced subunit vaccine
|
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
KR101515078B1
(ko)
|
2005-12-22 |
2015-04-24 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신
|
|
EP1988896A4
(en)
|
2006-02-22 |
2011-07-27 |
3M Innovative Properties Co |
CONJUGATES TO MODIFY IMMUNE REACTIONS
|
|
EP2476433A1
(en)
|
2006-03-30 |
2012-07-18 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
|
WO2007140958A2
(en)
|
2006-06-02 |
2007-12-13 |
Glaxosmithkline Biologicals S.A. |
Method for identifying whether a patient will be responder or not to immunotherapy
|
|
US7906506B2
(en)
|
2006-07-12 |
2011-03-15 |
3M Innovative Properties Company |
Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
|
|
US9364525B2
(en)
|
2006-07-18 |
2016-06-14 |
Glaxosmithkline Biologicals Sa |
Vaccines for malaria
|
|
US8323664B2
(en)
|
2006-07-25 |
2012-12-04 |
The Secretary Of State For Defence |
Live vaccine strains of Francisella
|
|
EP2433648A3
(en)
|
2006-10-12 |
2012-04-04 |
GlaxoSmithKline Biologicals S.A. |
Vaccine comprising an oil in water emulsion adjuvant
|
|
US20090285819A1
(en)
*
|
2006-11-15 |
2009-11-19 |
Functional Genetics, Inc. |
Methods and compositions for treating influenza
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
US20080149123A1
(en)
|
2006-12-22 |
2008-06-26 |
Mckay William D |
Particulate material dispensing hairbrush with combination bristles
|
|
PL2137210T3
(pl)
|
2007-03-02 |
2017-06-30 |
Glaxosmithkline Biologicals Sa |
Nowy sposób i kompozycje
|
|
BRPI0809926B8
(pt)
*
|
2007-04-04 |
2021-05-25 |
Infectious Disease Res Inst |
composição que compreende antígenos de mycobacterium tuberculosis, polipeptídeo de fusão isolado, polinucleotídeo isolado que codifica o dito polipeptídeo e uso da dita composição para estimular uma resposta imune protetora
|
|
PE20090146A1
(es)
|
2007-04-20 |
2009-03-23 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica contra el virus influenza
|
|
CA2690708A1
(en)
|
2007-06-26 |
2008-12-31 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
EA017887B1
(ru)
*
|
2007-08-02 |
2013-03-29 |
Байондвакс Фармасьютикалз Лтд. |
Полимерные мультиэпитопные вакцины против гриппа
|
|
AU2008300397A1
(en)
|
2007-09-17 |
2009-03-26 |
Glaxosmithkline Biologicals S.A. |
Improved detection of MAGE-A expression
|
|
US20090215710A1
(en)
*
|
2007-09-24 |
2009-08-27 |
Reliance Life Sciences Pvt. Ltd. |
Carbohydrate based toll-like receptor (tlr) antagonists
|
|
WO2009117035A1
(en)
|
2007-12-19 |
2009-09-24 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Soluble forms of hendra and nipah virus f glycoprotein and uses thereof
|
|
RU2010124788A
(ru)
*
|
2007-12-21 |
2012-01-27 |
Ваейт ЭлЭлСи (US) |
Генетически модифицированный ослабленный вирус везикулярного стоматита, композиции и способы их применения
|
|
JP5711972B2
(ja)
|
2007-12-24 |
2015-05-07 |
アイディー バイオメディカル コーポレイション オブ ケベック |
組換えｒｓｖ抗原
|
|
KR20100135886A
(ko)
|
2008-04-09 |
2010-12-27 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
액틴 세포 골격의 재배열 및 세포간 갭 형성을 조절하는 방법
|
|
ES2553113T3
(es)
|
2008-04-16 |
2015-12-04 |
Glaxosmithkline Biologicals S.A. |
Vacuna
|
|
EP2650014A2
(en)
|
2008-06-20 |
2013-10-16 |
Wyeth LLC |
Compositions and methods of use of ORF1358 from beta-hemolytic streptococcal strains
|
|
MX2011004755A
(es)
*
|
2008-11-05 |
2011-10-10 |
Wyeth Llc |
Composicion inmunogenica multicomponente para la prevencion de enfermedad estreptococica beta-hemolitica (bhs).
|
|
BRPI0922132A2
(pt)
|
2008-12-03 |
2018-10-23 |
Protea Vaccine Tech Ltd |
fragmentos glutamil trna sintetase (gts).
|
|
EP2373342B1
(en)
*
|
2008-12-23 |
2015-09-16 |
GlaxoSmithKline Biologicals S.A. |
Lipid a mimetics for use in inducing an immune response
|
|
WO2010079081A1
(en)
|
2009-01-07 |
2010-07-15 |
Glaxosmithkline Biologicals S.A. |
Methods for recovering a virus or a viral antigen produced by cell culture
|
|
GB0901411D0
(en)
|
2009-01-29 |
2009-03-11 |
Secr Defence |
Treatment
|
|
GB0901423D0
(en)
|
2009-01-29 |
2009-03-11 |
Secr Defence |
Treatment
|
|
US20110293660A1
(en)
|
2009-02-06 |
2011-12-01 |
Bruno Rene Andre |
Novel method
|
|
PE20110992A1
(es)
|
2009-02-17 |
2012-02-12 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica que comprende un antigeno del virus del dengue
|
|
SG174877A1
(en)
|
2009-03-17 |
2011-11-28 |
Mdxhealth Sa |
Improved detection of gene expression
|
|
AU2010233151A1
(en)
*
|
2009-04-09 |
2011-11-17 |
The University Of North Carolina At Chapel Hill |
Methods of treating edema related to ischemia-reperfusion
|
|
GB0906234D0
(en)
|
2009-04-14 |
2009-05-20 |
Secr Defence |
Vaccine
|
|
SA110310528B1
(ar)
|
2009-06-22 |
2014-07-02 |
Wyeth Llc |
التركيبات المولدة للمناعة لأنتيجينات ستافيلوكوكس أوريس
|
|
SG10201406432RA
(en)
|
2009-06-22 |
2014-11-27 |
Wyeth Llc |
Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
|
|
HUE028085T2
(en)
|
2009-06-24 |
2016-11-28 |
Glaxosmithkline Biologicals Sa |
Recombinant RSV antigens
|
|
EP2445527A2
(en)
|
2009-06-24 |
2012-05-02 |
ID Biomedical Corporation of Quebec |
Vaccine
|
|
CA2803282C
(en)
|
2009-07-06 |
2018-05-01 |
David E. Anderson |
Methods for preparing vesicles and formulations produced therefrom
|
|
JP5854559B2
(ja)
|
2009-07-06 |
2016-02-09 |
ヴァリエーション バイオテクノロジーズ インコーポレイテッド |
小胞を調製する方法及びこれから製造される製剤
|
|
CA2768186A1
(en)
|
2009-07-15 |
2011-01-20 |
Novartis Ag |
Rsv f protein compositions and methods for making same
|
|
GB0913680D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
GB0917457D0
(en)
|
2009-10-06 |
2009-11-18 |
Glaxosmithkline Biolog Sa |
Method
|
|
JP5774010B2
(ja)
|
2009-09-25 |
2015-09-02 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
インフルエンザウイルスのための免疫拡散アッセイ
|
|
GB0919117D0
(en)
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
|
WO2011067758A2
(en)
|
2009-12-02 |
2011-06-09 |
Protea Vaccine Technologies Ltd. |
Immunogenic fragments and multimers from streptococcus pneumoniae proteins
|
|
CA2797059A1
(en)
|
2010-05-03 |
2011-11-10 |
Glaxosmithkline Biologicals S.A. |
Novel method
|
|
GB201009273D0
(en)
|
2010-06-03 |
2010-07-21 |
Glaxosmithkline Biolog Sa |
Novel vaccine
|
|
PL2575870T3
(pl)
|
2010-06-04 |
2017-05-31 |
Wyeth Llc |
Preparaty szczepionek
|
|
WO2012006367A2
(en)
|
2010-07-06 |
2012-01-12 |
Variation Biotechnologies, Inc. |
Compositions and methods for treating influenza
|
|
CN107913396B
(zh)
|
2010-08-23 |
2022-03-08 |
惠氏有限责任公司 |
脑膜炎萘瑟氏菌rLP2086抗原的稳定制剂
|
|
AU2011300409B2
(en)
|
2010-09-10 |
2015-03-26 |
Wyeth Llc |
Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
|
|
GB201101331D0
(en)
|
2011-01-26 |
2011-03-09 |
Glaxosmithkline Biolog Sa |
Compositions and uses
|
|
CN106822883A
(zh)
|
2010-12-14 |
2017-06-13 |
葛兰素史密丝克莱恩生物有限公司 |
分枝杆菌抗原组合物
|
|
EP2654784B1
(en)
|
2010-12-22 |
2016-12-07 |
Wyeth LLC |
Stable immunogenic compositions of staphylococcus aureus antigens
|
|
US10736844B2
(en)
|
2011-01-13 |
2020-08-11 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
|
WO2012114323A1
(en)
|
2011-02-22 |
2012-08-30 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
|
|
EP2678005A4
(en)
|
2011-02-24 |
2015-06-10 |
Oncothyreon Inc |
GLUCOLOPOPEPTIDE MUC1-BASED VACCINE WITH AN ADJUVANS
|
|
CA2835644C
(en)
|
2011-05-13 |
2021-06-15 |
Novartis Ag |
Pre-fusion rsv f antigens
|
|
CN103533953A
(zh)
|
2011-05-17 |
2014-01-22 |
葛兰素史密丝克莱恩生物有限公司 |
针对肺炎链球菌的疫苗
|
|
JP6460789B2
(ja)
|
2011-06-03 |
2019-01-30 |
スリーエム イノベイティブ プロパティズ カンパニー |
ポリエチレングリコールセグメントを有するヘテロ２官能性リンカー及び該リンカーから調製された免疫反応調節複合体
|
|
BR112013031039B1
(pt)
|
2011-06-03 |
2020-04-28 |
3M Innovative Properties Co |
compostos de hidrazino 1h-imidazoquinolina-4-aminas, conjugados feitos destes compostos, composição e composição farmacêutica compreendendo ditos compostos e conjugados, usos dos mesmos e método de fabricação do conjugado
|
|
ITMI20111182A1
(it)
|
2011-06-28 |
2012-12-29 |
Canio Buonavoglia |
Vaccino per coronavirus canino
|
|
GB201113570D0
(en)
|
2011-08-05 |
2011-09-21 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
GB201116248D0
(en)
|
2011-09-20 |
2011-11-02 |
Glaxosmithkline Biolog Sa |
Liposome production using isopropanol
|
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
AU2013208693B2
(en)
|
2012-01-12 |
2017-12-07 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
|
EP2806894A4
(en)
|
2012-01-27 |
2015-11-04 |
Variation Biotechnologies Inc |
METHODS AND COMPOSITIONS FOR THERAPEUTIC AGENTS
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
MY198910A
(en)
|
2012-03-09 |
2023-10-02 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
|
WO2013139744A1
(en)
|
2012-03-18 |
2013-09-26 |
Glaxosmithkline Biologicals S.A. |
Method of vaccination against human papillomavirus
|
|
EP3492095A1
(en)
|
2012-04-01 |
2019-06-05 |
Technion Research & Development Foundation Limited |
Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
|
|
KR102057217B1
(ko)
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
HK1209140A1
(en)
|
2012-07-19 |
2016-03-24 |
Zoetis Services Llc |
Bovine influenza c virus compositions
|
|
WO2014018724A1
(en)
|
2012-07-27 |
2014-01-30 |
Zoetis Llc |
Tick toxin compositions
|
|
AU2013301312A1
(en)
|
2012-08-06 |
2015-03-19 |
Glaxosmithkline Biologicals S.A. |
Method for eliciting in infants an immune response against RSV and B. pertussis
|
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
|
DK2885007T3
(en)
|
2012-08-16 |
2018-12-03 |
Pfizer |
Methods for glycoconjugation and compositions
|
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
JP6502262B2
(ja)
|
2012-12-20 |
2019-04-17 |
ファイザー・インク |
糖複合化方法
|
|
CN103961697A
(zh)
|
2013-02-05 |
2014-08-06 |
日东电工株式会社 |
粘膜给予用疫苗组合物
|
|
EP2762157A1
(en)
|
2013-02-05 |
2014-08-06 |
Nitto Denko Corporation |
Vaccine composition for transdermal or mucosal administration
|
|
CA2840997A1
(en)
|
2013-02-05 |
2014-08-05 |
Nitto Denko Corporation |
Vaccine composition for transdermal administration
|
|
CN103961700A
(zh)
|
2013-02-05 |
2014-08-06 |
日东电工株式会社 |
粘膜给予用疫苗组合物
|
|
KR20140100419A
(ko)
|
2013-02-05 |
2014-08-14 |
닛토덴코 가부시키가이샤 |
경피 투여용 ｗｔ1 펩티드 암 백신 조성물
|
|
EP2762152A1
(en)
|
2013-02-05 |
2014-08-06 |
Nitto Denko Corporation |
WT1 peptide cancer vaccine composition for transdermal administration
|
|
RU2687026C2
(ru)
|
2013-02-05 |
2019-05-06 |
Нитто Денко Корпорейшн |
Вакцинная композиция против злокачественной опухоли на основе пептида wt1 для мукозального введения
|
|
IN2014CH00396A
(pl)
|
2013-02-05 |
2015-04-03 |
Nitto Denko Corp |
|
|
CN103961306A
(zh)
|
2013-02-05 |
2014-08-06 |
日东电工株式会社 |
经皮给予用疫苗组合物
|
|
KR102050931B1
(ko)
|
2013-02-05 |
2019-12-02 |
닛토덴코 가부시키가이샤 |
경피 투여용 ｗｔ1 펩티드 암 백신 테이프제
|
|
WO2014136064A2
(en)
|
2013-03-08 |
2014-09-12 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
EP2970398B1
(en)
|
2013-03-13 |
2024-05-08 |
The United States of America, as Represented by The Secretary, Department of Health and Human Services |
Prefusion rsv f proteins and their use
|
|
CN105188710A
(zh)
|
2013-03-15 |
2015-12-23 |
葛兰素史密丝克莱恩生物有限公司 |
包含缓冲的氨基烷基氨基葡糖苷磷酸酯衍生物的组合物及其用于增强免疫应答的用途
|
|
EP2983703A1
(en)
|
2013-03-15 |
2016-02-17 |
Zoetis Services LLC |
Cross-protection of bovines against b. trehalosi infection by a multi-valent vaccine
|
|
BE1022174B1
(fr)
|
2013-03-15 |
2016-02-24 |
Glaxosmithkline Biologicals S.A. |
Vaccin
|
|
EP2978447B1
(en)
|
2013-03-28 |
2019-05-08 |
Infectious Disease Research Institute |
Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis
|
|
WO2014183066A2
(en)
|
2013-05-10 |
2014-11-13 |
Whitehead Institute For Biomedical Research |
Protein modification of living cells using sortase
|
|
MX2016001695A
(es)
|
2013-08-05 |
2016-05-02 |
Glaxosmithkline Biolog Sa |
Composiciones inmunogenas de combinacion.
|
|
JP6851827B2
(ja)
|
2013-08-30 |
2021-03-31 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
細胞培養中でのウイルスの大規模製造
|
|
RU2662968C2
(ru)
|
2013-09-08 |
2018-07-31 |
Пфайзер Инк. |
Иммуногенная композиция против neisseria meningitidis (варианты)
|
|
JP2015059577A
(ja)
|
2013-09-17 |
2015-03-30 |
Ntn株式会社 |
チェーン伝動装置
|
|
CN104436157A
(zh)
|
2013-09-23 |
2015-03-25 |
恩金生物有限公司 |
流感疫苗和治疗
|
|
WO2015092710A1
(en)
|
2013-12-19 |
2015-06-25 |
Glaxosmithkline Biologicals, S.A. |
Contralateral co-administration of vaccines
|
|
WO2015095868A1
(en)
|
2013-12-20 |
2015-06-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
|
BR112016015835B1
(pt)
|
2014-01-21 |
2023-12-26 |
Pfizer Inc |
Processo de preparação de conjugados compreendendo polissacarídeos capsulares de streptococcus pneumoniae
|
|
PL3096786T3
(pl)
|
2014-01-21 |
2021-11-08 |
Pfizer Inc. |
Polisacharydy otoczkowe streptococcus pneumoniae i ich koniugaty
|
|
WO2016130569A1
(en)
|
2015-02-09 |
2016-08-18 |
Mj Biologics, Inc. |
A composition comprising pedv antigens and methods for making and using the composition
|
|
ES2701169T3
(es)
|
2014-02-14 |
2019-02-21 |
Pfizer |
Conjugados glucoproteicos inmunogénicos
|
|
US10821175B2
(en)
|
2014-02-25 |
2020-11-03 |
Merck Sharp & Dohme Corp. |
Lipid nanoparticle vaccine adjuvants and antigen delivery systems
|
|
CN106535930A
(zh)
|
2014-03-11 |
2017-03-22 |
明尼苏达大学董事会 |
猪流行性腹泻病毒疫苗及其使用方法
|
|
BE1022518B1
(fr)
|
2014-03-12 |
2016-05-19 |
Glaxosmithkline Biologicals S.A. |
Formulation liposomale immunogene
|
|
EP3116479A1
(en)
|
2014-03-12 |
2017-01-18 |
GlaxoSmithKline Biologicals S.A. |
Liposomal compositions for mucosal delivery
|
|
JP6550072B2
(ja)
|
2014-04-03 |
2019-07-24 |
バイオンドバックス ファーマシューティカルズ リミテッド |
多量体マルチエピトープインフルエンザポリペプチドの組成物及びそれらの生成
|
|
MX384992B
(es)
|
2014-06-13 |
2025-03-14 |
Glaxosmithkline Biologicals Sa |
Combinaciones inmunógenas.
|
|
AR101256A1
(es)
|
2014-07-21 |
2016-12-07 |
Sanofi Pasteur |
Composición vacunal que comprende ipv y ciclodextrinas
|
|
AR102547A1
(es)
|
2014-11-07 |
2017-03-08 |
Takeda Vaccines Inc |
Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso
|
|
AU2015252119A1
(en)
|
2014-11-07 |
2016-05-26 |
Takeda Vaccines, Inc. |
Hand, foot, and mouth vaccines and methods of manufacture and use thereof
|
|
EP3242883A4
(en)
|
2015-01-06 |
2018-10-17 |
ImmunoVaccine Technologies Inc. |
Lipid a mimics, methods of preparation, and uses thereof
|
|
MA41414A
(fr)
|
2015-01-28 |
2017-12-05 |
Centre Nat Rech Scient |
Protéines de liaison agonistes d' icos
|
|
WO2016132294A1
(en)
|
2015-02-19 |
2016-08-25 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
AU2015384786B2
(en)
|
2015-03-03 |
2020-08-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Display platform from bacterial spore coat proteins
|
|
MX380387B
(es)
|
2015-03-12 |
2025-03-12 |
Zoetis Services Llc |
Metodos de piolisina y composiciones.
|
|
MY182282A
(en)
|
2015-05-04 |
2021-01-18 |
Pfizer |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
|
CA2986961C
(en)
|
2015-05-26 |
2023-07-25 |
Ohio State Innovation Foundation |
Nanoparticle based vaccine strategy against swine influenza virus
|
|
TW201716084A
(zh)
|
2015-08-06 |
2017-05-16 |
葛蘭素史克智慧財產發展有限公司 |
組合物及其用途與治療
|
|
WO2017021912A1
(en)
|
2015-08-06 |
2017-02-09 |
Glaxosmithkline Intellectual Property Development Limited |
Combined tlrs modulators with anti ox40 antibodies
|
|
EP3331565A1
(en)
|
2015-08-06 |
2018-06-13 |
GlaxoSmithKline Intellectual Property Development Ltd |
Tlr4 agonists and compositions thereof and their use in the treatment of cancer
|
|
CA2995101A1
(en)
|
2015-08-14 |
2017-02-23 |
Zoetis Services Llc |
Mycoplasma bovis compositions
|
|
WO2017059280A1
(en)
|
2015-10-02 |
2017-04-06 |
The University Of North Carolina At Chapel Hill |
Novel pan-tam inhibitors and mer/axl dual inhibitors
|
|
EP3362089B1
(en)
|
2015-10-13 |
2023-12-06 |
Sanofi Pasteur |
Immunogenic compositions against s. aureus
|
|
EP3368092B9
(en)
|
2015-10-29 |
2020-07-29 |
Novartis AG |
Antibody conjugates comprising toll-like receptor agonist
|
|
CN107849084B
(zh)
|
2015-12-03 |
2021-09-14 |
葛兰素史密斯克莱知识产权发展有限公司 |
作为sting调节剂的环状嘌呤二核苷酸
|
|
WO2017098421A1
(en)
|
2015-12-08 |
2017-06-15 |
Glaxosmithkline Intellectual Property Development Limited |
Benzothiadiazine compounds
|
|
WO2017097783A1
(en)
|
2015-12-08 |
2017-06-15 |
Glaxosmithkline Biologicals S.A. |
Novel adjuvant formulations
|
|
WO2017123201A1
(en)
|
2016-01-11 |
2017-07-20 |
Zoetis Services Llc |
Novel cross protective vaccine compositions for porcine epidemic diarrhea virus
|
|
WO2017137085A1
(en)
|
2016-02-11 |
2017-08-17 |
Sanofi Pasteur |
Meningitidis vaccines comprising subtilinases
|
|
WO2017153952A1
(en)
|
2016-03-10 |
2017-09-14 |
Glaxosmithkline Intellectual Property Development Limited |
5-sulfamoyl-2-hydroxybenzamide derivatives
|
|
PT3440076T
(pt)
|
2016-04-07 |
2022-07-29 |
Glaxosmithkline Ip Dev Ltd |
Amidas heterocíclicas úteis como modeladores de proteína
|
|
JP2019510802A
(ja)
|
2016-04-07 |
2019-04-18 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
タンパク質調節物質として有用な複素環アミド
|
|
KR20190003699A
(ko)
|
2016-05-05 |
2019-01-09 |
글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 |
제스트 인핸서 상동체 2 억제제
|
|
US11033615B2
(en)
|
2016-05-31 |
2021-06-15 |
The Government of the United States, As Represented by the Secretary of the Army Fort Detrick, Maryland |
Zika virus vaccine and methods of production
|
|
EP3269385A1
(en)
|
2016-07-12 |
2018-01-17 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pneumococcal polysaccharide-protein conjugate composition
|
|
US11191822B2
(en)
|
2016-06-22 |
2021-12-07 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pneumococcal polysaccharide-protein conjugate composition
|
|
US20190241573A1
(en)
|
2016-07-20 |
2019-08-08 |
Glaxosmithkline Intellectual Property Development Limited |
Isoquinoline derivatives as perk inhibitors
|
|
EP3504230A1
(en)
|
2016-08-23 |
2019-07-03 |
GlaxoSmithKline Biologicals SA |
Fusion peptides with antigens linked to short fragments of invariant chain (cd74)
|
|
BR112019004913B1
(pt)
|
2016-09-16 |
2022-07-12 |
Infectious Disease Research Institute |
Vacinas que compreendem polipeptídeos de mycobacterium leprae para a prevenção, tratamento e diagnóstico de lepra
|
|
WO2018060288A1
(en)
|
2016-09-29 |
2018-04-05 |
Glaxosmithkline Biologicals S.A. |
Compositions and methods of treatment of persistent hpv infection
|
|
GB201616904D0
(en)
|
2016-10-05 |
2016-11-16 |
Glaxosmithkline Biologicals Sa |
Vaccine
|
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
WO2018100536A1
(en)
|
2016-12-01 |
2018-06-07 |
Glaxosmithkline Intellectual Property Development Limited |
Methods of treating cancer
|
|
US10695424B2
(en)
|
2016-12-07 |
2020-06-30 |
Glaxosmithkline Biologicals S.A. |
Method of making a liposome composition
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
US11084850B2
(en)
|
2016-12-16 |
2021-08-10 |
The Pirbright Institute |
Recombinant prefusion RSV F proteins and uses thereof
|
|
GB201621686D0
(en)
|
2016-12-20 |
2017-02-01 |
Glaxosmithkline Biologicals Sa |
Novel methods for inducing an immune response
|
|
AU2018215585B2
(en)
|
2017-01-31 |
2022-03-17 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
EP4656208A3
(en)
|
2017-01-31 |
2026-03-04 |
Merck Sharp & Dohme LLC |
Methods for making polysaccharide-protein conjugates
|
|
CN110225757A
(zh)
|
2017-01-31 |
2019-09-10 |
默沙东公司 |
由肺炎链球菌血清型19f生产荚膜多糖蛋白缀合物的方法
|
|
MX2019009869A
(es)
|
2017-02-24 |
2019-10-02 |
Merck Sharp & Dohme |
Formulaciones de vacunas de conjugado de neumococos.
|
|
GB201703529D0
(en)
|
2017-03-06 |
2017-04-19 |
Cambridge Entpr Ltd |
Vaccine composition
|
|
WO2018183666A1
(en)
|
2017-03-31 |
2018-10-04 |
Boston Medical Center Corporation |
Methods and compositions using highly converved pneumococcal surface proteins
|
|
WO2018193063A2
(en)
|
2017-04-19 |
2018-10-25 |
Institute For Research In Biomedicine |
Novel malaria vaccines and antibodies binding to plasmodium sporozoites
|
|
CN110621339A
(zh)
|
2017-04-28 |
2019-12-27 |
葛兰素史密丝克莱恩生物有限公司 |
疫苗接种
|
|
US11389465B2
(en)
|
2017-05-01 |
2022-07-19 |
Vanderbilt University |
Phosphorylated hexaacyl disaccharides (PHADs) for treating or preventing infections
|
|
GB201707700D0
(en)
|
2017-05-12 |
2017-06-28 |
Glaxosmithkline Biologicals Sa |
Dried composition
|
|
BR112019025104A2
(pt)
|
2017-05-30 |
2020-06-23 |
Glaxosmithkline Biologicals S.A. |
Método de fabricar um sistema de entrega não viral, sistema de entrega não viral, e, composição
|
|
GB2600653B
(en)
|
2017-05-30 |
2022-11-02 |
Glaxosmithkline Biologicals Sa |
Novel methods
|
|
MX2019015524A
(es)
|
2017-06-23 |
2020-09-10 |
Univ Maryland |
Composiciones inmunogenicas.
|
|
WO2019021208A1
(en)
|
2017-07-27 |
2019-01-31 |
Glaxosmithkline Intellectual Property Development Limited |
USEFUL INDAZOLE DERIVATIVES AS PERK INHIBITORS
|
|
CN111093650B
(zh)
|
2017-09-07 |
2024-03-01 |
默沙东有限责任公司 |
肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
|
|
WO2019053617A1
(en)
|
2017-09-12 |
2019-03-21 |
Glaxosmithkline Intellectual Property Development Limited |
CHEMICAL COMPOUNDS
|
|
US11524069B2
(en)
|
2017-09-13 |
2022-12-13 |
Sanofi Pasteur |
Human cytomegalovirus immunogenic composition
|
|
AU2018344902B2
(en)
|
2017-10-05 |
2021-06-03 |
Glaxosmithkline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (STING) useful in treating HIV
|
|
CA3077337A1
(en)
|
2017-10-05 |
2019-04-11 |
Glaxosmithkline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (sting)
|
|
JP7197880B2
(ja)
*
|
2017-10-19 |
2022-12-28 |
学校法人 名城大学 |
エステル化剤及びその利用
|
|
ES3058336T3
(es)
|
2017-12-06 |
2026-03-10 |
Merck Sharp & Dohme Llc |
Composiciones que comprenden conjugados polisacárido-proteína de Streptococcus pneumoniae y métodos de uso de los mismos
|
|
JP7362667B2
(ja)
|
2018-02-12 |
2023-10-17 |
イニミューン・コーポレーション |
Ｔｏｌｌ様受容体リガンド
|
|
JP7448954B2
(ja)
|
2018-02-21 |
2024-03-13 |
ザ ユニバーシティー オブ モンタナ |
ジアリールトレハロース化合物及びその使用
|
|
AU2019228381B2
(en)
|
2018-02-28 |
2021-12-16 |
Pfizer Inc. |
IL-15 variants and uses thereof
|
|
WO2019169313A1
(en)
|
2018-03-02 |
2019-09-06 |
The University Of Montana |
Immunogenic trehalose compounds and uses thereof
|
|
GB201807924D0
(en)
|
2018-05-16 |
2018-06-27 |
Ctxt Pty Ltd |
Compounds
|
|
MX2020012607A
(es)
|
2018-05-23 |
2021-01-29 |
Pfizer |
Anticuerpos especificos para gucy2c y sus usos.
|
|
KR102602329B1
(ko)
|
2018-05-23 |
2023-11-16 |
화이자 인코포레이티드 |
Cd3에 특이적인 항체 및 이의 용도
|
|
EP3574915A1
(en)
|
2018-05-29 |
2019-12-04 |
Neovacs |
Immunogenic product comprising il-4 and/or il-13 for treating disorders associated with aberrant il-4 and/or il 13 expression or activity
|
|
EP3807298A1
(en)
|
2018-06-12 |
2021-04-21 |
GlaxoSmithKline Biologicals S.A. |
Adenovirus polynucleotides and polypeptides
|
|
EP3581201A1
(en)
|
2018-06-15 |
2019-12-18 |
GlaxoSmithKline Biologicals S.A. |
Escherichia coli o157:h7 proteins and uses thereof
|
|
CN112566654A
(zh)
|
2018-07-31 |
2021-03-26 |
葛兰素史密丝克莱恩生物有限公司 |
抗原纯化方法
|
|
WO2020030571A1
(en)
|
2018-08-06 |
2020-02-13 |
Glaxosmithkline Intellectual Property Development Limited |
Combinations of a pd-1 antibody and a tlr4 modulator and uses thereof
|
|
WO2020030570A1
(en)
|
2018-08-06 |
2020-02-13 |
Glaxosmithkline Intellectual Property Development Limited |
Combinations of an ox40 antibody and a tlr4 modulator and uses thereof
|
|
WO2020031087A1
(en)
|
2018-08-06 |
2020-02-13 |
Glaxosmithkline Intellectual Property Development Limited |
Combination therapy
|
|
CN111315407B
(zh)
|
2018-09-11 |
2023-05-02 |
上海市公共卫生临床中心 |
一种广谱抗流感疫苗免疫原及其应用
|
|
EP3886901A1
(en)
*
|
2018-11-29 |
2021-10-06 |
GlaxoSmithKline Biologicals S.A. |
Methods for manufacturing an adjuvant
|
|
CR20210333A
(es)
|
2018-12-19 |
2021-08-18 |
Merck Sharp & Dohme |
Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y sus métodos de uso
|
|
EP3897846A1
(en)
|
2018-12-21 |
2021-10-27 |
GlaxoSmithKline Biologicals SA |
Methods of inducing an immune response
|
|
US20220370606A1
(en)
|
2018-12-21 |
2022-11-24 |
Pfizer Inc. |
Combination Treatments Of Cancer Comprising A TLR Agonist
|
|
US12496340B2
(en)
|
2019-05-23 |
2025-12-16 |
The University Of Montana |
Vaccine adjuvants based on TLR receptor ligands
|
|
EP3990494A1
(en)
|
2019-06-26 |
2022-05-04 |
GlaxoSmithKline Intellectual Property Development Limited |
Il1rap binding proteins
|
|
GB201910304D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
|
GB201910305D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
|
WO2021015987A1
(en)
|
2019-07-19 |
2021-01-28 |
Merck Sharp & Dohme Corp. |
Antigenic glycoprotein e polypeptides, compositions, and methods of use thereof
|
|
US20220273789A1
(en)
|
2019-07-21 |
2022-09-01 |
Glaxosmithkline Biologicals Sa |
Therapeutic viral vaccine
|
|
WO2021018941A1
(en)
|
2019-07-31 |
2021-02-04 |
Glaxosmithkline Intellectual Property Development Limited |
Methods of treating cancer
|
|
PH12022550110A1
(en)
|
2019-07-31 |
2022-12-12 |
Sk Bioscience Co Ltd |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
|
EP4021407A1
(en)
|
2019-08-30 |
2022-07-06 |
GlaxoSmithKline Biologicals S.A. |
Jet mixing lipid nanoparticle manufacturing process
|
|
WO2021043961A1
(en)
|
2019-09-06 |
2021-03-11 |
Glaxosmithkline Intellectual Property Development Limited |
Dosing regimen for the treatment of cancer with an anti icos agonistic antibody and chemotherapy
|
|
WO2021048081A1
(en)
|
2019-09-09 |
2021-03-18 |
Glaxosmithkline Biologicals Sa |
Immunotherapeutic compositions
|
|
WO2021059181A1
(en)
|
2019-09-27 |
2021-04-01 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
WO2021058711A2
(en)
|
2019-09-27 |
2021-04-01 |
Glaxosmithkline Intellectual Property Development Limited |
Antigen binding proteins
|
|
US12533418B2
(en)
|
2019-11-22 |
2026-01-27 |
Glaxosmithkline Biologicals Sa |
Dosage and administration of a bacterial saccharide glycoconjugate vaccine
|
|
CA3164623A1
(en)
|
2019-12-17 |
2021-06-24 |
Pfizer Inc. |
Antibodies specific for cd47, pd-l1, and uses thereof
|
|
EP4077318B1
(en)
|
2019-12-18 |
2025-10-15 |
Ctxt Pty Ltd |
Benzimidazole dimers as modulators of sting
|
|
BR112022015994A2
(pt)
|
2020-02-13 |
2022-10-11 |
Univ Illinois |
Composição imunogênica multivalente, vetor recombinante, célula hospedeira recombinante, e, métodos para induzir uma resposta imune protetora e para imunizar um animal contra dirofilariose
|
|
EP4136219A1
(en)
|
2020-04-16 |
2023-02-22 |
Par'Immune SAS |
28 kda gst proteins from schistosoma for the treatment of vasculitis
|
|
EP4136095A1
(en)
|
2020-04-17 |
2023-02-22 |
Regents of the University of Minnesota |
Sars-cov-2 spike receptor binding domain and compositions and methods thereof
|
|
EP3900739A1
(en)
|
2020-04-21 |
2021-10-27 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Synthetic streptococcus pneumoniae saccharide conjugates to conserved membrane protein
|
|
EP4146378A1
(en)
|
2020-05-05 |
2023-03-15 |
GlaxoSmithKline Biologicals S.A. |
Microfluidic mixing device and methods of use
|
|
EP4158352A1
(en)
|
2020-06-01 |
2023-04-05 |
Loop Diagnostics, S.L. |
Method and kit for the early detection of sepsis
|
|
WO2021245611A1
(en)
|
2020-06-05 |
2021-12-09 |
Glaxosmithkline Biologicals Sa |
Modified betacoronavirus spike proteins
|
|
IL299253A
(en)
|
2020-06-22 |
2023-02-01 |
Sumitomo Pharma Co Ltd |
Helps with TLR4 agonist activity
|
|
MX2023000662A
(es)
|
2020-07-17 |
2023-02-27 |
Pfizer |
Anticuerpos terapeuticos y sus usos.
|
|
KR20230056727A
(ko)
|
2020-08-26 |
2023-04-27 |
화이자 인코포레이티드 |
B군 스트렙토코쿠스 폴리사카라이드-단백질 접합체, 접합체를 생산하는 방법, 접합체를 포함하는 면역원성 조성물, 및 그의 용도
|
|
EP4213943A1
(en)
|
2020-09-15 |
2023-07-26 |
The University Of Montana |
Compositions and methods targeting filamentous bacteriophage
|
|
IL301402A
(en)
|
2020-09-17 |
2023-05-01 |
Inst Nat Sante Rech Med |
IMMUNOGENIC PRODUCT COMPRISING AN IgE FRAGMENT FOR TREATING IgE-MEDIATED INFLAMMATORY DISORDERS
|
|
TW202233200A
(zh)
|
2020-11-11 |
2022-09-01 |
日商第一三共股份有限公司 |
新穎胺基烷基葡萄胺糖苷4-磷酸衍生物
|
|
JP2023553854A
(ja)
|
2020-12-02 |
2023-12-26 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ドナー鎖補完性ｆｉｍｈ
|
|
EP4032547A1
(en)
|
2021-01-20 |
2022-07-27 |
GlaxoSmithKline Biologicals S.A. |
Hsv1 fce derived fragements for the treatment of hsv
|
|
EP4288087A1
(en)
|
2021-02-03 |
2023-12-13 |
The Board of Trustees of the University of Illinois |
Vaccine and methods for preventing filariasis and dirofilariasis
|
|
MX2023009456A
(es)
|
2021-02-11 |
2023-08-28 |
Glaxosmithkline Biologicals Sa |
Preparacion de la vacuna contra el vph.
|
|
CA3212345A1
(en)
|
2021-03-02 |
2022-09-09 |
Glaxosmithkline Intellectual Property Development Limited |
Substituted pyridines as dnmt1 inhibitors
|
|
JP2024511831A
(ja)
|
2021-03-31 |
2024-03-15 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド |
抗原結合タンパク質およびそれらの組み合わせ
|
|
WO2023020994A1
(en)
|
2021-08-16 |
2023-02-23 |
Glaxosmithkline Biologicals Sa |
Novel methods
|
|
WO2023020992A1
(en)
|
2021-08-16 |
2023-02-23 |
Glaxosmithkline Biologicals Sa |
Novel methods
|
|
WO2023020993A1
(en)
|
2021-08-16 |
2023-02-23 |
Glaxosmithkline Biologicals Sa |
Novel methods
|
|
CN118510790A
(zh)
|
2021-12-13 |
2024-08-16 |
美国政府(由卫生和人类服务部的部长所代表) |
噬菌体λ-疫苗系统
|
|
CN114318353B
(zh)
*
|
2021-12-27 |
2023-12-05 |
广东红日星实业有限公司 |
一种除灰剂及其制备方法和应用
|
|
WO2024069420A2
(en)
|
2022-09-29 |
2024-04-04 |
Pfizer Inc. |
Immunogenic compositions comprising an rsv f protein trimer
|
|
WO2025106603A1
(en)
|
2023-11-16 |
2025-05-22 |
Merck Sharp & Dohme Llc |
Peptide conjugate vaccine compositions and methods for the treatment of alzheimer's disease
|
|
EP4656648A1
(en)
|
2024-05-31 |
2025-12-03 |
Consejo Superior De Investigaciones Científicas |
Immunomodulatory thiourea and urea carbohydrate compounds and uses thereof
|
|
WO2026038177A1
(en)
|
2024-08-16 |
2026-02-19 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|